Company Starpharm Srl with Fiscal Code 18428353
recorded a turnover of 2025 of
426.520,
with a net profit of
12.486
and having an average number of employees of
3.
The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Starpharm Srl
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Sales - EUR
213.354
211.845
223.347
240.218
283.202
287.621
323.062
375.249
420.938
426.520
Total Income - EUR
223.974
222.086
229.654
243.125
284.733
289.033
324.047
375.260
420.970
426.528
Total Expenses - EUR
211.515
211.782
216.238
232.406
269.655
276.635
310.250
358.250
409.071
411.305
Gross Profit/Loss - EUR
12.459
10.304
13.416
10.719
15.078
12.398
13.797
17.009
11.899
15.223
Net Profit/Loss - EUR
10.310
8.606
11.119
8.292
12.810
9.854
10.874
13.667
9.824
12.486
Employees
3
3
3
3
3
3
3
3
3
3
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 2.7%, from 420.938 euro in the year 2024, to 426.520 euro in 2025.
The Net Profit increased by 2.793 euro, from 9.824 euro in 2024, to 12.486 in the last year.
Check the financial reports for the company - Starpharm Srl
Financial Rating - STARPHARM SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Starpharm Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Starpharm Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Starpharm Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
130.167 euro in 2025 which includes Inventories of
54.692 euro, Receivables of
45.535 euro and cash availability of
29.940 euro.
The company's Equity was valued at
26.329 euro, while total Liabilities amounted to
110.722 euro.
Equity decreased by -804 euro, from 27.500 euro in 2024, to 26.329 in 2025.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Starpharm Srl